These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8779785)

  • 1. [Etiology of rheumatic diseases].
    Ito K
    Ryumachi; 1996 Jun; 36(3):491-2. PubMed ID: 8779785
    [No Abstract]   [Full Text] [Related]  

  • 2. [HLA-antigen (human leukocyte antigens) and rheumatoid arthritis. Relation to the etiology of the disease?].
    Gran JT; Husby G; Thorsby E
    Tidsskr Nor Laegeforen; 1980 Aug; 100(23):1350-2. PubMed ID: 7456012
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis.
    Shibue T; Tsuchiya N; Komata T; Matsushita M; Shiota M; Ohashi J; Wakui M; Matsuta K; Tokunaga K
    Arthritis Rheum; 2000 Apr; 43(4):753-7. PubMed ID: 10765919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Symposium: Etiology of rheumatic diseases. 3. (A) Their relationship with infection--the role of bacterial component in the course of experimental induction of chronic rheumatoid arthritis].
    Aoki S; Ikuta K; Shimizu M
    Ryumachi; 1973 Oct; 13(4):338-41. PubMed ID: 4608926
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans.
    Rodríguez-Carreón AA; Zúñiga J; Hernández-Pacheco G; Rodríguez-Pérez JM; Pérez-Hernández N; Montes de Oca JV; Cardiel MH; Granados J; Vargas-Alarcón G
    J Autoimmun; 2005 Feb; 24(1):63-8. PubMed ID: 15725578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis.
    Naguwa SM
    Ann N Y Acad Sci; 2005 Jun; 1051():709-15. PubMed ID: 16127011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
    Feldmann M; Brennan F; Paleolog E; Taylor P; Maini RN
    Eur Cytokine Netw; 1997 Sep; 8(3):297-300. PubMed ID: 9346366
    [No Abstract]   [Full Text] [Related]  

  • 8. The yin and yang of rheumatoid arthritis.
    Birmingham K
    J Clin Invest; 2003 Oct; 112(8):1126. PubMed ID: 14561693
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
    Bondeson J; Maini RN
    Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models.
    Kassiotis G; Kollias G
    J Clin Invest; 2001 Jun; 107(12):1507-8. PubMed ID: 11413157
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
    Choy E
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
    Sugiyama E
    Clin Calcium; 2007 Apr; 17(4):528-34. PubMed ID: 17404481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On a possible viral etiology of rheumatoid arthritis.
    Smith CA
    J Rheumatol; 1979; 6(2):113-6. PubMed ID: 458784
    [No Abstract]   [Full Text] [Related]  

  • 14. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL; Gause A
    Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of cytokines in the pathogenesis of rheumatoid arthritis.
    Feldmann M; Maini RN
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in genes encoding tumor necrosis factor-alpha and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis.
    Pinto JA; Rego I; Rodríguez-Gomez M; Cañete JD; Fernandez-López C; Freire M; Fernandez-Sueiro JL; Sanmarti R; Blanco FJ
    J Rheumatol; 2008 Jan; 35(1):177-8. PubMed ID: 18176993
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype.
    Newton J; Brown MA; Milicic A; Ackerman H; Darke C; Wilson JN; Wordsworth BP; Kwiatkowski D
    Arthritis Rheum; 2003 Jan; 48(1):90-6. PubMed ID: 12528108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility genes in rheumatoid arthritis].
    Okamoto K; Tamiya G; Inoko H
    Ryumachi; 2000 Dec; 40(6):917-26. PubMed ID: 11210777
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheumatic diseases: the effects of inflammation on bone.
    Walsh NC; Crotti TN; Goldring SR; Gravallese EM
    Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis. Introduction.
    Corr M
    Springer Semin Immunopathol; 2003 Aug; 25(1):1-2. PubMed ID: 12904887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.